WuXi AppTec Denies Unauthorized IP Transfer Allegations Amidst Strong Financial Performance
WuXi AppTec (SHA: 603259, HKG: 2359), a China-based Contract Research, Development, and Manufacturing Organization (CRDMO)...
Policy / Regulatory
China Unveils Management Measures to Strengthen National Health Emergency Teams
The National Health Commission (NHC), National Administration of Traditional Chinese Medicine, and National Disease Control...
China’s NHC Mandates Enhanced Management and Accessibility of Midwifery Services
The National Health Commission (NHC) has issued a notification with the aim of enhancing the...
NMPA Mandates Electronic Permits for Anesthetic Drugs and Psychotropic Substances
The National Medical Products Administration (NMPA) has issued a new notification aimed at enhancing the...
National Drug Sampling Inspection Report Reveals High Compliance Rates in 2023
The National Institute for Food and Drug Control (NIFDC) has released its “National Drug Sampling...
China’s National Adverse Drug Reaction Report for 2023 Highlights Stability in Reporting Trends
The National Center for ADR Monitoring has released its “National Adverse Drug Reaction Monitoring Annual...
Kobayashi Pharmaceutical Recalls Red Yeast Rice Pills in China Amid Health Concerns
Japan-based Kobayashi Pharmaceutical has reportedly initiated a product recall in the Chinese market for its...
Surprise Resignation: Congressman Gallagher Steps Down as Biosecure Act Faces Uncertainty
U.S. Congressman Mike Gallagher, the key proponent behind the recently introduced Biosecure Act aimed at...
China’s Commerce Minister Meets with Global Pharma Leaders to Discuss Innovation Cooperation
China’s Minister of Commerce, Wang Wentao, convened a high-level meeting with top executives from the...
China Unveils Action Plan to Boost Foreign Investment and Open Economy Further
The State Council of China has unveiled an ambitious “Action Plan to Promote the High-Level...
China Expands Medical Service Pricing Reform with Three Additional Pilot Provinces
The National Healthcare Security Administration (NHSA) has announced an expansion of its medical services pricing...
China’s National Joint Procurement Office Sets March 2024 for Insulin Contracts Renewal
The National Joint Procurement Office in China has released a notification outlining the information and...
CDE Seeks Public Feedback on Latest Batch of Generic Drug Reference Preparations
The Center for Drug Evaluation (CDE), a key regulatory body overseeing pharmaceutical evaluations in China,...
Legend Biotech’s Carvykti Earns FDA Committee’s Unanimous Recommendation for Expanded Use
GenScript Biotech Corporation (HKG: 1548), a Contract Research Organization (CRO) based in China, has announced...
BIO Reverses Support for WuXi AppTec Amid Security Concerns, Plans Legislative Shift
The Biotech Innovation Organization (BIO), a US-based industry lobbying group, has reversed its stance on...
Shanghai Unveils 17 Measures to Enhance Medical Administration Business Environment
Shanghai’s Medical Product Administration has unveiled a comprehensive set of 17 measures aimed at fostering...
NMPA Releases 78th Batch of Reference Drugs for Generic Quality Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 78th batch of reference drugs for...
China’s NHC Outlines Cross-departmental Law Enforcement to Strengthen Medical Supervision
The National Health Commission (NHC) has issued a set of “Opinions on Strengthening Cross-departmental Law...
China Cracks Down on Medical Insurance Fraud with New Guidelines and Increased Prosecutions
China’s Supreme People’s Court, along with the Supreme People’s Procuratorate and the Ministry of Public...
US Senate Committee Backs Bill to Restrict Chinese Biotechnology Firms’ Access to American Genetic Data
The U.S. Senate’s homeland security committee has voted 11-1 in favor of the Prohibiting Foreign...